Summary:Evoked potentials have assisted in the diagnosis of multiple sclerosis for years, but the potential to demonstrate pathophysiologic change has prompted a reconsideration of their potential role as outcome measures in clinical trials of multiple sclerosis. The use of any surrogate end point or biomarker in clinical trials requires a thorough understanding of that end point's performance characteristics and utility in a particular setting. This article explores regulatory issues regarding the use of biomarkers and surrogate end points in clinical trials of multiple sclerosis with particular emphasis on challenges faced by evoked potential studies.

Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues / Skeen, M. B.; Pani, L.. - In: JOURNAL OF CLINICAL NEUROPHYSIOLOGY. - ISSN 0736-0258. - 38:3(2021), pp. 181-185. [10.1097/WNP.0000000000000732]

Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues

Pani L.
2021

Abstract

Summary:Evoked potentials have assisted in the diagnosis of multiple sclerosis for years, but the potential to demonstrate pathophysiologic change has prompted a reconsideration of their potential role as outcome measures in clinical trials of multiple sclerosis. The use of any surrogate end point or biomarker in clinical trials requires a thorough understanding of that end point's performance characteristics and utility in a particular setting. This article explores regulatory issues regarding the use of biomarkers and surrogate end points in clinical trials of multiple sclerosis with particular emphasis on challenges faced by evoked potential studies.
38
3
181
185
Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues / Skeen, M. B.; Pani, L.. - In: JOURNAL OF CLINICAL NEUROPHYSIOLOGY. - ISSN 0736-0258. - 38:3(2021), pp. 181-185. [10.1097/WNP.0000000000000732]
Skeen, M. B.; Pani, L.
File in questo prodotto:
File Dimensione Formato  
Biomarkers_and_Surrogate_End_points_in_Multiple.5.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 76.93 kB
Formato Adobe PDF
76.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1279842
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact